News
FDA approves Fitbit’s AFib-detection software
Fitbit has gained approval for an algorithm that will power an upcoming AFib-detection feature.
News
POISE-3 backs wider use of tranexamic acid in noncardiac surgery
The antifibrinolytic agent significantly reduced the risk for bleeding in a wide array of major noncardiac surgeries, suggesting an expanded role...
News
Icosapent ethyl approved for cardiovascular risk reduction
The Food and Drug Administration’s decision on reduction of events in high-risk patients was based primarily on the REDUCE-IT trial results.
News
Hyperkalemia-related treatment changes linked to death in acute HF
It’s not the potassium, but the subsequent dosage reduction, that may boost mortality after hospitalization for acute heart failure.
Video
‘Phenomenal’ REDUCE-IT establishes triglyceride theory
Why did REDUCE-IT succeed while other trials and compounds failed? Dr. Deedwania explains that it, for the first time, used the appropriate...
News
Rivaroxaban gains indication for prevention of major cardiovascular events in CAD/PAD
Rivaroxaban (Xarelto) is the first direct oral anticoagulant to gain an indication for prevention of cardiovascular events.
Audio
Metabolic swings predict death, hold the antiplatelet, and more
Listen to the week’s top news on Cardiocast.
Audio
Top news from TCT, anticoagulation guidelines, and more
Listen to the week’s news on Cardiocast.
News
Eluvia drug-eluting vascular stent approved on heels of TCT presentation
The stent system made a splash at TCT 2018.
News
TCT presents new, ‘massive’ integrated, hands-on learning center
TCT is going back to its roots with a huge new training center.